{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:54:57Z","timestamp":1771512897121,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T00:00:00Z","timestamp":1581724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T00:00:00Z","timestamp":1581724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Amgen, Inc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s40120-020-00179-3","type":"journal-article","created":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T09:02:37Z","timestamp":1581757357000},"page":"93-103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Care Among Migraine Patients in a Commercially Insured Population"],"prefix":"10.1007","volume":"9","author":[{"given":"Machaon","family":"Bonafede","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"McMorrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Noxon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandhya","family":"Sapra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Silberstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,15]]},"reference":[{"issue":"Suppl 1","key":"179_CR1","first-page":"9","volume":"24","author":"Headache Classification Subcommittee of the International Headache Society","year":"2004","unstructured":"Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd edition. Cephalalgia. 2004;24[Suppl 1]:9\u2013160.","journal-title":"Cephalalgia."},{"issue":"7","key":"179_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1046\/j.1526-4610.2001.041007646.x","volume":"41","author":"RB Lipton","year":"2001","unstructured":"Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41(7):646\u201357.","journal-title":"Headache."},{"issue":"6","key":"179_CR3","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1212\/WNL.55.6.754","volume":"55","author":"SD Silberstein","year":"2000","unstructured":"Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55(6):754\u201362.","journal-title":"Neurology."},{"key":"179_CR4","unstructured":"American Migraine Foundation. Preventive treatments. 2016. https:\/\/americanmigrainefoundation.org\/understanding-migraine\/preventive-treatments\/. Accessed 4 Feb 2020."},{"key":"179_CR5","unstructured":"Institute for Clinical and Economic Review (ICER). Calcitonin gene-related peptide (CGRP) inhibitors as preventive treatments for patients with episodic or chronic migraine: effectiveness and value. California Technology Assessment Forum: Institute for Clinical and Economic Review; 2018."},{"issue":"5","key":"179_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11916-019-0768-y","volume":"23","author":"I Urits","year":"2019","unstructured":"Urits I, Jones MR, Gress K, et al. CGRP antagonists for the treatment of chronic migraines: a comprehensive review. Curr Pain Headache Rep. 2019;23(5):29.","journal-title":"Curr Pain Headache Rep"},{"issue":"5","key":"179_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","volume":"68","author":"RB Lipton","year":"2007","unstructured":"Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343\u20139.","journal-title":"Neurology."},{"issue":"1","key":"179_CR8","doi-asserted-by":"publisher","first-page":"7510","DOI":"10.4081\/ni.2018.7510","volume":"10","author":"G Viticchi","year":"2018","unstructured":"Viticchi G, Falsetti L, Bartolini M, et al. Migraine: incorrect self-management for a disabling disease. Neurol Int. 2018;10(1):7510.","journal-title":"Neurol Int."},{"issue":"11","key":"179_CR9","first-page":"1169","volume":"23","author":"M Bonafede","year":"2017","unstructured":"Bonafede M, Cai Q, Cappell K, et al. Factors associated with direct health care costs among patients with migraine. J Manag Care Spec Pharm. 2017;23(11):1169\u201376.","journal-title":"J Manag Care Spec Pharm."},{"issue":"4","key":"179_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/08998280.2013.11929007","volume":"26","author":"FG Freitag","year":"2013","unstructured":"Freitag FG, Lyss H, Nissan GR. Migraine disability, healthcare utilization, and expenditures following treatment in a tertiary headache center. Bayl Univ Med Cent Proc. 2013;26(4):363\u20137.","journal-title":"Bayl Univ Med Cent Proc."},{"issue":"2","key":"179_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10194-011-0405-6","volume":"13","author":"J Wu","year":"2012","unstructured":"Wu J, Hughes MD, Hudson MF, Wagner PJ. Antimigraine medication use and associated health care costs in employed patients. J Headache Pain. 2012;13(2):121\u20137.","journal-title":"J Headache Pain."},{"key":"179_CR12","unstructured":"American Academy of Neurology. Axon registry. 2016. https:\/\/www.aan.com\/practice\/axon-registry. Accessed 4 Feb 2020."},{"key":"179_CR13","unstructured":"American Migraine Foundation. American Registry for Migraine Research. 2016. https:\/\/americanmigrainefoundation.org\/about-us\/armr\/. Accessed 4 Feb 2020."},{"issue":"6","key":"179_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"179_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s13311-017-0592-1","volume":"15","author":"JJY Ong","year":"2018","unstructured":"Ong JJY, De Felice M. Migraine treatment: current acute medications and their potential mechanisms of action. Neurotherapeutics. 2018;15(2):274\u201390.","journal-title":"Neurotherapeutics."},{"issue":"Suppl 1","key":"179_CR16","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.4103\/0972-2327.99998","volume":"15","author":"S Miller","year":"2012","unstructured":"Miller S. The acute and preventative treatment of episodic migraine. Ann Indian Acad Neurol. 2012;15[Suppl 1]:S33\u20139.","journal-title":"Ann Indian Acad Neurol."},{"issue":"3","key":"179_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/2040622315579627","volume":"6","author":"MW Weatherall","year":"2015","unstructured":"Weatherall MW. The diagnosis and treatment of chronic migraine. Ther Adv Chronic Dis. 2015;6(3):115\u201323.","journal-title":"Ther Adv Chronic Dis."},{"issue":"4","key":"179_CR18","first-page":"368","volume":"20","author":"A Messali","year":"2014","unstructured":"Messali A, Owens G, Bloudek L, Kori S, Cole A, Chia J. Health care resource utilization following initiation of a triptan: a retrospective claims analysis. J Manag Care Spec Pharm. 2014;20(4):368\u201375.","journal-title":"J Manag Care Spec Pharm."},{"issue":"2","key":"179_CR19","first-page":"137","volume":"11","author":"Etemad LRea","year":"2005","unstructured":"Etemad LRea. Costs and utilization of triptan users who receive drug prophylaxis for migraine versus triptan users who do not receive drug prophylaxis. J Manag Care Pharm. 2005;11(2):137\u201344.","journal-title":"J Manag Care Pharm"},{"issue":"1","key":"179_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s10194-019-1039-3","volume":"20","author":"MFP Peres","year":"2019","unstructured":"Peres MFP, Swerts DB, de Oliveira AB, Silva-Neto RP. Migraine patients\u2019 journey until a tertiary headache center: an observational study. J Headache Pain. 2019;20(1):88.","journal-title":"J Headache Pain."},{"issue":"4","key":"179_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11916-018-0681-9","volume":"22","author":"O Viswanath","year":"2018","unstructured":"Viswanath O, Rasekhi R, Suthar R, Jones MR, Peck J, Kaye AD. Novel interventional nonopioid therapies in headache management. Curr Pain Headache Rep. 2018;22(4):29.","journal-title":"Curr Pain Headache Rep"},{"key":"179_CR22","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1017\/S1463423618000324","volume":"20","author":"PTG Davies","year":"2019","unstructured":"Davies PTG, Lane RJM, Astbury T, Fontebasso M, Murphy J, Matharu M. The long and winding road: the journey taken by headache sufferers in search of help. Prim Health Care Res Dev. 2019;20:e4.","journal-title":"Prim Health Care Res Dev."}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-020-00179-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-020-00179-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-020-00179-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T13:17:37Z","timestamp":1712841457000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-020-00179-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,15]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["179"],"URL":"https:\/\/doi.org\/10.1007\/s40120-020-00179-3","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,15]]},"assertion":[{"value":"26 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}